Ridindex Monthly Chart:
Ridindex Since Inception (05/06/2025) Chart:
🟢 Full transparency. You can view the current open book HERE
Core Themes:
Capital-cycle energy & industrials – offshore services, pump/valve OEMs in multi-year cap-ex up-cycle.
AI & semiconductor stack – GPU leaders, test equipment, robotics plays riding infra build-out.
Alternative beta – Bitcoin miners, strategic metals for non-correlated torque.
Structural shorts – legacy SaaS and consumer tech facing slowing unit economics + valuation risk.
🏆 Top 5 Contributors In June:
NVDA (+0.48%) – Relentless AI-infrastructure demand. (Article)
BKSY (+0.39%) – Awarded multi-year U.S. government imagery contract. (tactical trade mentioned in substack chat)
TDW (+0.32%) – Tight OSV supply, insider buys. (Article)
TER (+0.28%) – HBM / chiplet test-equipment orders inflect; margin guide raised. (Article)
CLSK (+0.27%) – Hash-rate expansion plus spot-BTC bid lifts miner complex. (Article)
💣 Largest Drawdowns In June:
SPY 08/15/25 P540 (-1.29%) – Index resilience + vol crush hit deep OTM hedge. (Article)
TOI (-0.21%) – Guidance cut on payer-mix headwinds. (Article)
CRCL (Short) (-0.21%) – Post-IPO squeeze, valuation flagged vs. TAM reality. (Tactical trade from substack chat)
RBLX (Short) (-0.21%) – Insider selling was not enough to offset interest in DAU growth. (Article)
NET (Short) (-0.17%) – Multiple expansion continues to drive shares higher. (Article)
🔍 Watchlist & Tactical Pipeline:
We’re actively monitoring the following themes for potential entry:
Hot Iron, Cold Corpses
Data-center cap-ex is rushing toward flash and HBM-soaked racks; rotational media is being left to rust. Follow the hyperscaler build-sheets.
Blue-Collar Boomers vs. the Doom Machine
Reshoring has trades-labor day-rates exploding, while macro-doomers bid up convex catastrophe hedges. A self-lifting barbell of cashflow and convexity.
Superobjects Rising
Architectures where AIs transact with AIs and humans are mere metadata. Long the machine-to-machine rails, short the gig-economy middlemen.
The Weight Shift
Injections replacing interventions: GLP-1s are reallocating calories, procedures, and profit pools. Lean into the lifesavers, fade the leftovers.
Final Notes
The Ridindex is built for real exposure, sized with conviction, and hedged with flexibility. Trades go live in real time, performance is tracked and transparent. Next review lands after July close, see you next month. Until then, stay sharp.
Disclaimer:
Ridire Research is an independent research publication operated by Ridire Research LLC and affiliated with a private fund, an Exempt Reporting Adviser under the U.S. Investment Advisers Act of 1940. Ridire Research is not registered as an investment adviser and does not provide personalized investment, legal, accounting, or tax advice.Informational & Educational Purpose Only
All materials—including text, charts, model portfolios, and explicit labels such as “Buy,” “Sell,” “Hold,” “Long,” or “Short”—are published solely for general informational and educational purposes. They reflect the author’s views at the time of writing, derived from publicly available data, proprietary frameworks, and market analysis, and are not tailored to any reader’s specific objectives, financial situation, or risk tolerance. Subscription to this Substack does not create an adviser–client relationship with the affiliated private fund or its principals.
No Offer or Solicitation
Nothing herein constitutes (i) an offer to sell or the solicitation of an offer to buy any security or other instrument, (ii) a recommendation to participate in any investment strategy, or (iii) a solicitation for investment advisory services. Any references to trades, allocations, or vehicles should be viewed as hypothetical model illustrations only. Offers, if ever made, will be made solely by confidential offering documents and only to qualified investors in jurisdictions where permitted.
Potential Conflicts of Interest
The affiliated private fund, its affiliates, employees, and related accounts may hold, increase, decrease, initiate, or exit positions, long or short, in securities or digital assets discussed, without notice or obligation to update disclosures. Such positions may be inconsistent with views expressed in this publication. The affiliated private fund, related entities, and personnel may initiate, modify, or exit positions in any mentioned security before or after publication without further notice. We maintain internal policies, including trading blackout windows and conflict reviews, to mitigate potential conflicts of interest.
Accuracy & Forward-Looking Statements
Although we strive for accuracy and analytical rigor, information may become outdated and may contain errors or omissions. Forward-looking statements, projections, or target prices are inherently uncertain and may differ materially from actual results. No warranty, express or implied, is given as to completeness, accuracy, or reliability.
Risk Acknowledgment
Investing involves substantial risk, including the potential for complete loss of capital. Past performance, whether actual, indicated by back-tests, or modeled, is not indicative of future results. Securities, derivatives, and digital assets mentioned may be illiquid, highly volatile, or subject to regulatory change.
Reader Responsibility
Readers should conduct their own due diligence, consider their personal circumstances, and consult a licensed financial professional before acting on any information contained herein. By reading this publication you agree that Ridire Research LLC, the affiliated private fund, and their affiliates accept no liability for any direct or consequential loss arising from reliance on the information presented. This research is not directed at persons in jurisdictions where such distribution would be contrary to local law.